Previous Article | Next Article ![]()
Infection and Immunity, April 2000, p. 1905-1911, Vol. 68, No. 4
Laboratory of Molecular Parasitology, New
York Blood Center, New York, New York,1 and
Tropical Medicine Research Station2 and
District Referal Hospital,3 Kumba,
Cameroon
Received 22 July 1999/Returned for modification 30 September
1999/Accepted 11 January 2000
Antigen-specific interleukin-5 (IL-5), gamma interferon (IFN- Our present knowledge of
antionchocerca immunity comes from three basic approaches: correlative
and immunoepidemiological studies of human populations living in areas
in which onchocerciasis is endemic, in vitro studies, and in vivo
studies using defined animal models. The studies of human populations
have provided evidence that naturally acquired immunity against
Onchocerca volvulus infection can occur in humans. First,
within regions where onchocerciasis is endemic, 1 to 5% of the
population who have been exposed to high transmission rates of
infection have no clinical manifestations of the disease and are thus
distinguished as the putatively immune individuals (PI) (12, 16,
48). Second, in infected individuals (INF) the number of skin
microfilariae (Smf) tends to level off between 20 and 40 years of age,
which suggests an acquired means of limiting infection (10).
Third, sera from both the PI and the INF have been shown to promote in
vitro opsonization and killing of the infective third-stage larvae (L3)
and to limit molting of L3 to fourth-stage larvae (18, 20).
Experimental studies using animal models have shown that antigens from
L3 and the subsequent developmental stages of molting L3 (mL3) are
promising sources for protective antigens and the targets for control
of filarial infections (11, 30, 31, 41). Partial protection
against O. volvulus L3 challenge has been achieved by
immunization of mice with irradiated L3 (25, 30, 39, 45) and
vaccination with recombinant O. volvulus larval antigens
(19, 23, 46). In the Acanthocheilonema viteae
Jird model protection was elicited by irradiated L3, supernatants from
L3 cultured in vitro, and live mL3 but not by live L3 (11,
31). In addition, in the cat-Brugia pahangi model,
animals that were exposed to a repeated infection with L3 developed
immunity against an L3 challenge infection (7, 8).
Protective responses in humans against the infective stages of the
parasite would prevent the development of adult worms and microfilariae
(mf) that cause the disease.
In efforts to define the mechanisms of immunity against O. volvulus in humans, the cellular and humoral immune responses in the PI have been compared with those in the INF. Because of the scarcity of larval antigens, previous studies have been limited to
antigens of O. volvulus adult worms, which contain
microfilarial antigens as well. In most of these studies the humoral
and cellular immune responses in PI were found to differ from those in
INF, providing more acceptance that the observed clinical difference between the two groups is associated with immune system-mediated resistance (3-5, 12, 13, 32, 36, 37, 38, 43, 44, 47, 48).
Some of these studies have concluded that protective immunity in the PI
appeared to be accompanied by diminished specific immunoglobulin E
(IgE), IgG, and IgG subclass responses and an enhanced production of
interleukin-2 (IL-2) and gamma interferon (IFN- In the onchocerca mouse model, where the challenge infection consists
of L3 implanted in diffusion chambers, immune responses of the Th2 type
including the production of IL-4, IL-5, IgE, and eosinophil-mediated
effector reactivity were shown to account for the partial protection
induced by immunization with irradiated O. volvulus L3
(25). The importance of Th2-type responses for mediating
protection against L3 in mice was subsequently determined by cytokine
depletion experiments (26) and after using IL-4 and IFN- Given that T cells play a critical role in regulating the immune
response, determining the stage specificity of the T-cell responses is
essential for understanding protective immunity against the parasite.
While previous cellular studies of onchocerciasis were restricted to
the use of antigens from the adult worms, in this study we have
examined for the first time the cytokine responses (IL-5, IFN- Study population.
The study was performed in the Kumba
region, an area of hyperendemicity for onchocerciasis in southwest
Cameroon. A total of 1,440 individuals who were either born or had
lived in this region for at least 10 years received thorough physical,
parasitological, and ophthalmological examinations, and skin biopsies
taken from right and left hips and calves determined the number of
O. volvulus mf. One hundred sixty-eight of these individuals
(11.7%) were negative for Smf and were classified mf negative
(mf Antigens.
All parasite material was collected in our
research facility at the Tropical Medicine Research Station, Kumba,
Cameroon. Crude antigen extracts were prepared from different stages of
O. volvulus including L3 (obtained from infected black
flies), mL3, adult female worms, adult male worms, and Smf. mL3 were
generated by incubating L3 in vitro in solution containing a 1:1
mixture of Iscove modified Dulbecco medium and NCTC-135, 20% fetal
calf serum, and antibiotic-antimycotic solution (GIBCO BRL Life
Technologies, Gaithersburg, Md.) for 3 days at 37°C (6).
Larvae were collected after 1, 2, or 3 days in culture, washed in
phosphate-buffered saline (PBS), and quick-frozen in liquid nitrogen.
Ultrastructural examination of such larvae by electron microscopy
confirmed that the cultured larvae had started the molting process, as
the separation between the cuticle of L3 and the newly synthesized
cuticle of the fourth-stage larvae was evident in the cross sections
(33). The mL3 antigen preparation was made from a pooled
mixture of similar numbers of larvae that were collected on day 1, 2, or 3 in culture. Crude L3, mL3, and Smf antigens and antigens from F-OvAg and M-OvAg were prepared as described before (48).
Briefly, the worms were ground to a powder using a Bessman tissue
pulverizer (Spectrum Lab Products, Houston, Tex.) and further disrupted
by sonication before extraction in PBS containing 10 mM
3-(3-cholamidopropyl)-dimethylammonio-2-hydroxy-1-propanesulfonate (Calbiochem, San Diego, Calif.) and protease inhibitors (Sigma, St.
Louis, Mo.; 2 mM phenylmethylsulfonyl fluoride, 0.2 mM
N- Lymphocyte stimulation.
PBMC from each individual were
isolated by density gradient centrifugation over Ficoll (Sigma). Cells
were cultured at 2 × 106/ml in RPMI 1640 medium
containing 10% heat-inactivated fetal calf serum, 25 mM HEPES, 2 mM
L-glutamine, and 50 µg of gentamicin (BioWhittaker,
Walkersville, Md.)/ml (13). The cells were cultured for 5 days in the presence of the following final concentrations of antigen
preparations: F-OvAg at 5 µg/ml; L3 antigen at 0.5 µg/ml
(equivalent to 50 L3/ml); mL3 antigen at 0.36 µg/ml (equivalent to 50 mL3/ml); Smf antigen at 0.25 µg/ml (equivalent to 500 Smf/ml), and
M-OvAg at 2 µg/ml. The antigens were used at concentrations determined to give optimal responses in the exposed individuals. Similar antigen concentrations have been shown to induce significant proliferation in PI and INF in comparison to controls from areas where
the disease is not endemic (data not shown). The cytokine response to a
nonparasite antigen was obtained by using streptolysin-O (1:100; Difco,
Detroit, Mich.). In addition, the PBMC were cultured in the presence of
a mitogenic stimulus of phorbol myristate acetate (50 ng/ml) plus
ionomycin (1 µg/ml) (Calbiochem) (13). The supernatants were harvested at day 5 and stored at Cytokine production and statistical analysis.
The quantities
of the cytokines IL-5, IFN- Enhanced Th1- and Th2-type responses in PI in response to L3 and
mL3 antigens.
The PBMC from both the PI and the INF produced IL-5
in response to the L3 antigens; however, the PI produced significantly more of the cytokine than the INF (Fig.
1). Second, significantly more PI
produced IL-5 (83.3%) than IFN-
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Immunity to Onchocerciasis: Cells from Putatively
Immune Individuals Produce Enhanced Levels of Interleukin-5, Gamma
Interferon, and Granulocyte-Macrophage Colony-Stimulating Factor in
Response to Onchocerca volvulus Larval and Male Worm
Antigens
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
),
and granulocyte-macrophage colony-stimulating factor (GM-CSF) responses
in individuals living in an area of hyperendemicity for onchocerciasis
in Cameroon were examined. The responses against antigens prepared from
Onchocerca volvulus third-stage larvae (L3), molting L3
(mL3), and crude extract from adult males (M-OvAg) were compared to the
responses against antigens from adult female worms and skin
microfilariae. Cytokine responses for the putatively immune individuals
(PI) and the infected individuals (INF) were compared. A differential
cytokine profile of IL-5 (Th2 phenotype) and IFN-
(Th1 phenotype)
was found in these individuals in response to the antigens. In both the
PI and the INF, Th2 responses against all the antigens tested were
dominant. However, in the PI group as a whole, there was an enhanced
Th2 response against the larval antigens and the adult male and adult
female antigens, and a Th1 response in a subgroup of the PI (27 to
54.5%) against L3, mL3, and M-OvAg antigens was present. While the PI
produced significantly higher levels of GM-CSF against L3, mL3, and
M-OvAg antigens than the INF, there was no difference in the GM-CSF
responses of the groups against the other antigens. The present study
indicated that, in comparison to the INF, the PI have distinct
larva-specific and adult male-specific cytokine responses, thus
supporting the premise that immunological studies of the PI would lead
to the identification of immune mechanisms and the target genes that play a role in protective immunity.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
) in response to
adult worm antigens, a profile suggesting protective Th1-type responses
(24, 32, 37, 43, 44). However, in recent studies done in
Benin, the PI were found to produce prominently IL-2, IL-5, and
granulocyte-macrophage colony-stimulating factor (GM-CSF) in response
to adult worm antigens and thus exhibited no predominance of the
Th1-type cytokine response or had a strict Th1 or Th2 dichotomy
(3).
knockout mice for immunization (22).
, and
GM-CSF) produced by peripheral blood mononuclear cells (PBMC) from the
PI and the INF to antigens from L3 and mL3, the stages shown to be more
relevant to protective immunity (1, 25, 45), and crude
extracts prepared from adult male worms (M-OvAg). These responses were
compared to those induced by antigens from crude extracts prepared from
adult female worms (F-OvAg) which contained microfilarial antigens, and
from Smf. It is the adult female and Smf stages that result in patent
infection and disease.
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
), whereas individuals positive for Smf were grouped
as INF. In order to identify the PI, the biopsies of the
mf
individuals were tested for the presence of a tandem
repeat DNA specific for O. volvulus. The O. volvulus 150-mer DNA repeats were amplified by PCR and identified
by Southern blotting using a specific internal O. volvulus
probe (35). This confirmatory test resulted in a subgroup of
51 individuals (3.6% of the total 1,440 surveyed, 30% of those
mf
) that were negative for Smf and negative by PCR
(mf
PCR
). Furthermore, this subgroup did
not exhibit any clinical signs of the disease and was thus classified
as the PI group (12). The PI were examined every 6 months
for clinical manifestations of onchocerciasis, and four skin biopsies
were taken from each individual. All maintained their mf
PCR
status and had no new clinical signs of
onchocerciasis for an additional 2 years. Fifty percent of the INF and
90% of the PI were 15 years of age or less. Twelve PI (5 to 15 years
of age) and 26 INF (with Smf ranging from 0.25 to 174 per skin snip)
matched for age and sex consented to participate in this study. The
individuals were from villages around Kumba: Marumba I, Marumba II, Boa
Bakundu, Bombanda, and Bombele.
-p-tosyl-L-lysine chloromethyl
ketone, 0.2 nM N-tosyl-L-phenylalanine
chloromethyl ketone, 25 µg of leupeptin/ml, 10 mM EDTA). The
insoluble material was extracted twice in the same buffer for 12 h
at 4°C. The pooled soluble extracts of each stage-specific
preparation were then dialyzed against PBS, centrifuged at 4°C, and
filter sterilized.
70°C until analyzed for IL-5
(marker for Th2 phenotype), IFN-
(marker for Th1 phenotype), and
GM-CSF cytokine production. We determined the antigen-specific GM-CSF
production because GM-CSF is known to enhance the activity of
neutrophils, basophils, monocytes, and eosinophils (17). These cellular components of the immune response can participate in
antibody-dependent cellular cytotoxicity, an effector mechanism that
was shown to be important for protective immunity against filarial and
other helminth diseases (34, 40).
, and GM-CSF present in the culture
supernatants were measured by using commercial sandwich enzyme-linked
immunosorbent assay kits (R & D Systems, Minneapolis, Minn.). Cytokine
levels were expressed in picograms per milliliter. The net
antigen-specific production of a cytokine was calculated by subtracting
the quantity of the cytokine produced by PBMC cultured without antigen
from that produced by PBMC cultured with a specific antigen. Because
the distribution of the data was not normal, comparisons between PI and
INF were made by the nonparametric Mann-Whitney U test. Fisher's exact
test (F test) was used for comparison of the response rates, responders
versus nonresponders, in the different study groups. Cytokine
production was considered positive if the individual had a net
production above 10 pg/ml.
![]()
RESULTS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
(27%) (P = 0.012;
F test) and significantly more INF produced IL-5 (75%) than IFN-
(4%) (P
0.0001; F test), indicating that Th2
responses against L3 antigens are predominant in both groups.
Interestingly, in the PI, L3 antigens also induced significantly higher
levels of IFN-
than in the INF, albeit low median levels in both
groups (Fig. 1). Although the IFN-
levels were statistically higher
in the PI than in the INF, it should be noted that the significance of this difference is based on only 27% of the PI producing the cytokine in comparison to 4% of the INF. It seems therefore that the PI group
is divided into two distinct immunological subgroups when stimulated
with L3 antigens: PBMC of eight individuals produced only IL-5 and no
IFN-
, while PBMC of three produced both. Third, PBMC from the PI
produced higher levels of GM-CSF than PBMC from the INF after
stimulation with L3 antigens (median values: PI, 47.6 pg/ml; INF,
14.5 pg/ml) although the GM-CSF levels in the PI are not quite
significantly higher than those in the INF (Fig. 1; P = 0.058). The INF on the other hand exhibited only a Th2 phenotype
(IL-5) in response to the L3 antigens.

View larger version (14K):
[in a new window]
FIG. 1.
Cytokine responses to L3 antigens in PI and INF. Values
for IL-5 (PI, n = 12; INF, n = 24),
IFN-
(PI, n = 11; INF, n = 24), and
GM-CSF (PI, n = 12; INF, n = 9) levels
are depicted. The statistical significance between the groups is
indicated by the P value. The Mann-Whitney U test was used
to test the significance by comparing the medians, which are indicated
by horizontal lines.
, and GM-CSF than those from the INF
(Fig. 2). The significant Th1 response in
the PI is attributed to 54.5% of the group, again implying the
presence of two distinct subgroups, one that has only a Th2 response
and the other that has a mixed Th1/Th2 response. In comparison, the INF
exhibited only a Th2 phenotype in response to the mL3 antigens, as
significantly more INF produced IL-5 (78%) than IFN-
(21.7%) (P = 0.0003; F test).
|
Enhanced Th1- and Th2-type responses in PI in response to antigens
from adult male worms (M-OvAg).
Our interest in the possible
contribution of adult male worms to protective immunity arose after we
found by using Western blot analysis that sera from the PI had
recognized unique proteins (molecular masses of 250, 57, 45, 36, 34, and 28 kDa) in adult male worm extracts not recognized by sera from the
INF (21). These results suggested that male-specific
antigens could probably induce antimale cellular and/or humoral
responses that promote the killing or block the development of male
worms. This will impede the reproduction and release of mf by
fertilized female worms and result in an occult and nonpatent infection
that might also account for the clinical status of the PI: lack of Smf
and clinical manifestations of the disease (12). When the
cytokine responses in response to M-OvAg were evaluated, the PBMC from the PI were found to produce significantly higher quantities of IL-5,
IFN-
, and GM-CSF in response to M-OvAg than the INF (Fig. 3). The elevated Th1 response in the PI
is attributed to 54.5% of the group, once more implying the presence
of two distinct subgroups, one that has only a Th2 response and the
other that has a mixed Th1/Th2 response. In comparison, the INF
exhibited only a Th2 phenotype in response to the M-OvAg, as
significantly more INF produced IL-5 (80%) than IFN-
(5%)
(P = 0.0001; F test).
|
Enhanced Th2-type response in PI in response to antigens from adult
female worms (F-OvAg).
In response to F-OvAg, PBMC from both the
PI and the INF produced IL-5; however, the PI produced significantly
more of the cytokine than the INF (Fig.
4). Moreover, significantly more PI and
INF produced IL-5 than produced IFN-
. One hundred percent of the PI
produced IL-5 versus 54.5% that produced IFN-
(P = 0.013; F test), and 88% of the INF produced IL-5 versus 38% that produced IFN-
(P = 0.0004; F test). Thus, in both
the PI and the INF, F-OvAg antigens induced a Th2-type response, with
the PI exhibiting an elevated Th2 response. PBMC from the PI and the INF produced comparable levels of GM-CSF and IFN-
in response to
F-OvAg (Fig. 4).
|
Th2-type response in PI and INF in response to antigens from
Smf.
Analysis of the IL-5, IFN-
, and GM-CSF levels produced in
response to Smf antigens indicated that the PBMC from both the PI and
the INF produced similar amounts of each of the cytokines (Fig.
5). The number of individuals producing
IL-5 was compared with the number of individuals producing IFN-
, and
it seems that more PI produced IL-5 (66.6%) than IFN-
(27%) and
that significantly more INF produced IL-5 (65%) than IFN-
(15%)
(P = 0.009; F test) in response to Smf antigens. Thus,
qualitatively, both the PI and the INF exhibited a predominant Th2
response to Smf antigens.
|
Cytokine responses induced by a mitogen and a nonparasitic
antigen.
The PBMC from both the PI and the INF produced similarly
high levels of IL-5 and IFN-
(more than 500 pg/ml) in response to a
mitogenic stimulus (phorbol myristate acetate plus ionomycin) or
streptolysin-O, a nonparasitic antigen (data not shown). Mitogen and
nonparasitic antigen stimulation of the PBMC revealed that, while the
cells of both groups had equivalent capacities to produce both
cytokines, the inability of PBMC from the INF and some of the PI to
produce IFN-
was O. volvulus antigen specific.
| |
DISCUSSION |
|---|
|
|
|---|
Although the existence of immunity to O. volvulus
infection is supported by the presence of PI individuals in areas where onchocerciasis is highly endemic, there has been no investigation of
the underlying mechanisms of specific antilarval cellular responses, which could prevent the establishment of infective larvae in these individuals. To date all of the correlative and immunoepidemiological studies of human populations living in areas of endemicity for onchocerciasis were done using adult worm antigens based on their ready
availability rather than on their ability to protect against incoming
infective larvae. PI from Ecuador and Togo were shown to secrete
predominately IFN-
in response to adult worm antigens, which
supported the theory that Th1-type responses are correlated with
protection (13, 43). However, in a study from Benin, PBMC
from PI secreted only the IL-5 and GM-CSF cytokines and furthermore the
PI produced significantly more of both cytokines than the INF
(3), implying a Th2 type of response. Thus, no clear and consistent correlation between distinct cellular immune responses to
adult antigens and immunity has been established.
This is the first study describing the cytokine responses of human T
cells to larval and adult male antigens of O. volvulus in
individuals who live in a region of hyperendemicity for O. volvulus. When the PBMC from the PI and the INF groups of
individuals were cultured in the presence of two distinct larval
antigens (L3 and mL3 antigens) and adult worm antigens (M-OvAg), a
differential cytokine profile was found (Fig. 1 to 3). First, although
an IL-5 response (Th2) was present in both the PI and the INF in
response to L3, mL3, and M-OvAg antigens, the PI group as a whole had a significantly elevated IL-5 response to these antigens. Second, in
comparison to the INF, a subgroup of the PI also had significantly elevated IFN-
responses to L3 (27%), mL3 (54.5%), and M-OvAg (54.5%) antigens. Third, the PI secreted higher levels of GM-CSF in
response to L3, mL3, and M-OvAg antigens. In contrast, the F-OvAg and
Smf antigens induced only a Th2-type response in the PI group. The INF
conversely exhibited only a Th2 phenotype in response to the L3, mL3,
and M-OvAg antigens as well as in response to F-OvAg and the Smf
antigen. The levels of other cytokines, IL-4 (Th2) and IL-2 (Th1), were
negligible in both groups against all antigens (data not shown).
The importance of the predominant Th2 responses for protective immunity in humans against the O. volvulus infective-stage larvae is corroborated by the Th2 responses seen in mice that were protected against an L3 challenge following immunization with irradiated O. volvulus larvae (22, 26). One possible Th2-mediated protective mechanism in the PI could be through the elevated and specific IL-5 and GM-CSF cytokine responses against L3 and mL3 antigens observed in this study. Both cytokines are able to augment the number of cells from the granulocyte-macrophage lineage (neutrophils, eosinophils, and basophils) and enhance their activity (17). GM-CSF in conjunction with IL-5 was also shown to induce eosinophil-specific chemotaxis (27). As a result, these major Th2-associated effector cells, in combination with larva-specific antibodies, could participate in antibody-dependent antilarval cell-mediated cytotoxicity reactions. This is corroborated by previous studies where we found that human neutrophils were capable of promoting antibody-mediated killing of O. volvulus L3 as well as the inhibition of L3 molting in vitro (20, 21). Furthermore, in vitro studies by Leke et al. (29) have shown specific serum-mediated leucocyte adherence to O. volvulus L3 in uninfected individuals in comparison to no significant adherence in highly infected individuals. In the O. volvulus mouse model, maximal levels of eosinophils and the presence of IL-5 in the diffusion chambers were coincident with the time of parasite killing in protected animals (26).
In addition to the PI having a significant and elevated Th2 response as
a whole when stimulated by L3, mL3, and M-OvAg antigens there was a
subgroup that also had a distinct Th1 response, albeit in small
quantities. The presence of both Th1 and Th2 responses in this subgroup
suggests that not all PI have a complete bias towards a Th2 response.
Even though the Th1 response in the present study was only apparent in
a subgroup of the PI (27 to 54.5%) and the mean net production of
IFN-
in the group as a whole was mostly less than 30 pg/ml for any
antigen, it still points to the possibility that some of the PI have
potentially more than one mechanism of protective immunity against
larvae and adult male worms. In a study conducted in Liberia
(14), a mixed Th1/Th2 type of immune response was observed
in response to the S1 protein, a distinct protective recombinant larval
protein of O. volvulus (2, 19). The S1 protein
was preferentially recognized by IgG3 antibodies of the PI in that
study and induced both IFN-
and IL-5 secretion by S1
antigen-specific CD4+ T cells from the PI (9).
Those authors have suggested that the induction of both IFN-
and
IL-5 responses by the S1 protein may trigger in vivo macrophage- and
eosinophil-dependent killing of L3. Th1 cytokines can stimulate the
macrophage cells (15), which, together with antigen-specific
antibodies, could also participate in antibody-dependent cellular
cytotoxicity reactions against larval stages. Th1 cells can produce
IgG1, and Th2 cells can produce IgE and IgG3 cytophilic antibodies.
Specific killing of the O. volvulus larvae would prevent the
establishment of an infection. Although the mechanisms by which either
Th1 or Th2 cells and their products mediate specific killing of the
filarial parasite remain to be elucidated, there is evidence for both
Th1- and Th2-type responses being protective in many helminthic
infections, depending on the particular model used (13, 34).
In the Brugia malayi mouse model it was clearly shown that
the host protective immune responses were not dependent on the
predominate Th2-type response that was elicited by the filarial
parasite, as T-cell populations other than Th2 cells were also capable
of conferring protection against L3 (28). However, to
confirm the role of Th1-type responses in protective immunity against
O. volvulus would require additional investigations using a
larger PI study group, optimal antigen concentrations for stimulation,
and more sensitive detection assays for secreted or intracellular
IFN-
.
Of particular interest are our results regarding the IL-5, IFN-
, and
GM-CSF responses in the PI to male antigens (M-OvAg), which were
similar to those observed in response to L3 and mL3 antigens (Fig. 3).
These responses may account for the induction of antimale cellular and
humoral responses that could promote the killing, or block the
development, of male worms. This would impede the reproduction and
release of mf by the female worms and result in an occult and nonpatent
infection. In onchocerciasis and lymphatic filariasis, it is believed
that PI and healthy individuals from areas of endemicity more likely
represent a heterogeneous group of individuals capable of controlling
the development of infective larvae or of having an occult filarial
infection (12). Absent the ability to distinguish those that
are truly immune to infection from those who may have an occult
infection, further analysis of the immune responses of the PI to the
different stage-specific recombinant antigens versus the responses to
crude antigens may further elucidate the nature of stage-specific
protective immunity. It would be important in future studies to include
PI who are older than 15 years of age, thus allowing a more appropriate
immunological representation of such a group.
In the INF, the response against the larval stages was predominantly of
the Th2 type, as significantly more of the INF produced IL-5 than
IFN-
. It seemed that the IFN-
response in the INF group as a
whole was down regulated in the presence of O. volvulus antigens, as many of the INF had antigen-specific levels of the cytokine below zero (Fig. 1 to 5). The down regulation of the Th1-type
response in the INF to parasite antigens was previously shown to be
correlated with the appearance of mf in the skin and is believed to be
induced by the mf (42). The Th2 response in the INF,
although significantly lower than in the PI, could provide the INF with
antilarval protective immunity as well, immunity that can protect the
already-infected individuals from new infections with L3. Such
immunity, which is termed concomitant immunity, has been shown to be
present in lymphatic filariasis and other helminthic infections
(34).
In conclusion, our observations showed for the first time that in
comparison to the INF the PI have distinct and specific antilarval and
antimale cytokine responses. The PI as a whole produced enhanced GM-CSF
and IL-5 cytokine levels and had a predominant Th2 type of response,
with a subgroup of PI also producing IFN-
(Th1), while the INF
produced only IL-5 (Th2). Although the mechanisms of immunity are not
clear, this study provides evidence that both Th2-type and
GM-CSF-mediated responses are important for protective immunity. The
Th1-mediated responses require more studies. This study also pointed
out the possibility that adult male worms may provide an additional new
target for vaccine development. These results are important not only
because they contribute to the understanding of the parasite
stage-specific immune responses in humans but also because of their
relevance to current investigations of potentially protective
recombinant antigens. Studies to determine the T-cell responses in
humans to defined antigens derived from different stages of the
parasite and to identify those antigens that are capable of inducing
protective immune responses are under way. As the responses in humans
are highly heterogeneous, a viable vaccine might need to consist of a
pool of antigens from different stages of the parasite that could
elicit a broad range of responses providing protection to all
individuals who live in areas of endemicity for onchocerciasis.
| |
ACKNOWLEDGMENTS |
|---|
We thank the people of the villages around Kumba, Marumba I, Marumba II, Boa Bakundu, Bombanda and Bombele, Cameroon, that have participated in the study and the personnel at the Tropical Medicine Research Station for their help throughout the course of the study. We thank David Abraham, Amy Klion, and Cohava Gelber for critical review of the manuscript.
The study was partially supported by grant RO1 AI 42328-02 from the National Institutes of Health.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Laboratory of Molecular Parasitology, The Lindsley F. Kimball Research Institute, New York Blood Center, 310 East 67th St., New York, NY 10021. Phone: (212) 570-3119. Fax: (212) 570-3121. E-mail: slustigm{at}server.nybc.org.
Editor: T. R. Kozel
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Bancroft, A. J., R. K. Grencis, K. J. Else, and E. Devaney. 1993. Cytokine production in BALB/c mice immunized with radiation attenuated third stage larvae of the filarial nematode, Brugia pahangi. J. Immunol. 150:1395-1402[Abstract]. |
| 2. | Bradley, J. E., L. Elson, T. I. Tree, G. Stewart, R. Guderian, M. Calvopina, W. Paredes, E. Araujo, and T. B. Nutman. 1995. Resistance to Onchocerca volvulus: differential cellular and humoral responses to a recombinant antigen, OvMBP20/11. J. Infect. Dis. 172:831-837[Medline]. |
| 3. | Brattig, N., C. Nietz, S. Hounkpatin, R. Lucius, F. Seeber, U. Pichlmeier, and T. Pogonka. 1997. Differences in cytokine responses to Onchocerca volvulus extract and recombinant Ov33 and OvL3-1 proteins in exposed subjects with various parasitologic and clinical states. J. Infect. Dis. 176:838-842[Medline]. |
| 4. | Brattig, N. W., F. W. Tischendorf, E. J. Albiez, D. W. Buttner, and J. Berger. 1987. Distribution pattern of peripheral lymphocyte subsets in localized and generalized form of onchocerciasis. Clin. Immunol. Immunopathol. 44:149-159[Medline]. |
| 5. | Brattig, N. W., I. Krawietz, A. Z. Abakar, K. D. Erttmann, T. F. Kruppa, and A. Massougbodji. 1994. Strong IgG isotypic antibody response in sowdah type onchocerciasis. J. Infect. Dis. 170:955-961[Medline]. |
| 6. | Cupp, E. W., M. J. Bernardo, A. E. Kiszewski, M. Trpis, and H. R. Taylor. 1988. Large scale production of the vertebrate infective stage (L3) of Onchocerca volvulus (Filarioidea: Onchocerciadae). Am. J. Trop. Med. Hyg. 38:596-600. |
| 7. | Denham, D. A., P. B. McGreevy, R. R. Suswillo, and R. Rogers. 1983. The resistance to re-infection of cats repeatedly inoculated with infective larvae of Brugia pahangi. Parasitology 86:11-18. |
| 8. | Denham, D. A., and C. Fletcher. 1987. The cat infected with Brugia pahangi as a model of human filariasis. Ciba Found. Symp. 127:225-235[Medline]. |
| 9. |
Doetze, A.,
K. D. Erttmann,
M. Y. Gallin,
B. Fleischer, and A. Hoerauf.
1997.
Production of both IFN-gamma and IL-5 by Onchocerca volvulus S1 antigen-specific CD4+ T cells from putatively immune individuals.
Int. Immunol.
9:721-729 |
| 10. | Duke, B. O. L., and P. R. Moore. 1968. The contribution of different age groups to the transmission of onchocerciasis in a Cameroon forest village. Trans. R. Soc. Trop. Med. Hyg. 62:22-29[CrossRef][Medline]. |
| 11. | Eisenbeiss, W. F., H. Apfel, and T. F. Meyer. 1994. Protective immunity linked with distinct developmental stage of filarial parasite. J. Immunol. 152:735-742[Abstract]. |
| 12. | Elson, L. H., R. H. Guderian, E. Araujo, J. E. Bradley, A. Days, and T. B. Nutman. 1994. Immunity to onchocerciasis: identification of a putatively immune population in a hyperendemic area of Ecuador. J. Infect. Dis. 169:588-594[Medline]. |
| 13. | Elson, L. H., H. Manuel Calvopina, Y. Wilson Paredes, N. Edmundo Araujo, J. E. Bradley, R. H. Guderian, and T. B. Nutman. 1995. Immunity to onchocerciasis: putative immune persons produce a Th1-like response to Onchocerca volvulus. J. Infect. Dis. 171:652-658[Medline]. |
| 14. | Erttmann, K. D., D. W. Buttner, and M. Y. Gallin. 1995. A putative protein related to human chemokines encoded antisense to the cDNA of an Onchocerca volvulus antigen. Trop. Med. Parasitol. 46:123-130[Medline]. |
| 15. | Flieger, D., U. Spengler, I. Beier, R. Kleinschmidt, A. Hoff, M. Varvenne, T. Sauerbruch, and I. Schmidt-Wolf. 1999. Enhancement of antibody dependent cellular cytotoxicity (ADCC) by combination of cytokines. Hybridoma 18:63-68[Medline]. |
| 16. | Gallin, M. Y., K. Edmonds, J. J. Ellner, K. D. Erttmann, A. T. White, H. S. Newland, H. R. Taylor, and B. M. Greene. 1988. Cell-mediated immune responses in human infection with Onchocerca volvulus. J. Immunol. 146:1999-2007. |
| 17. | Gasson, J. C., J. K. Fraser, and S. D. Nimer. 1990. Human granulocyte-macrophage colony-stimulating factor (GM-CSF): regulation of expression. Prog. Clin. Biol. Res. 338:27-41[Medline]. |
| 18. | Greene, B. M., H. R. Taylor, and M. Aikawa. 1985. Humoral and cellular immune responses to Onchocerca volvulus infection in humans. Rev. Infect. Dis. 7:789-795[Medline]. |
| 19. | Jenkins, R. E., M. J. Taylor, N. Gilvary, and A. E. Bianco. 1996. Characterization of a secreted antigen of Onchocerca volvulus with host-protective potential. Parasite Immunol. 18:29-42[CrossRef][Medline]. |
| 20. | Johnson, E. H., M. Irvine, P. H. Kass, J. Browne, M. Abdullai, A. M. Prince, and S. Lustigman. 1994. Onchocerca volvulus: in vitro cytotoxic effects of human neutrophils and serum on third-stage larvae. Trop. Med. Parasitol. 45:331-335[Medline]. |
| 21. | Johnson, E. H., S. Lustigman, P. H. Kass, M. Irvine, J. Browne, and A. M. Prince. 1995. Onchocerca volvulus: a comparative study of in vitro neutrophil killing of microfilariae and humoral responses in infected and endemic normals. Exp. Parasitol. 81:9-19[CrossRef][Medline]. |
| 22. | Johnson, E. H., S. Schynder-Candrian, T. V. Rajan, F. K. Nelson, S. Lustigman, and D. Abraham. 1998. Immune responses to third stage larvae of Onchocerca volvulus in interferon-gamma and interleukin-4 knockout mice. Parasite Immunol. 20:319-324[CrossRef][Medline]. |
| 23. | Joseph, G. T., T. Huima, and S. Lustigman. 1998. Characterization of an Onchocerca volvulus L3-specific larval antigen, Ov-ALT-1. Mol. Biochem. Parasitol. 96:177-183[CrossRef][Medline]. |
| 24. | King, C. L., and T. B. Nutman. 1991. Regulation of the immune response in lymphatic filariasis and onchocerciasis. Immunol. Today 12:A54-A58[CrossRef][Medline]. |
| 25. | Lange, A. M., W. Yutanawiboonchai, J. B. Lok, M. Trpis, and D. Abraham. 1993. Induction of protective immunity against larval Onchocerca volvulus in a mouse model. Am. J. Trop. Med. Hyg. 49:783-788. |
| 26. | Lange, A. M., W. Yutanawiboonchai, P. Scott, and D. Abraham. 1994. IL-4 and IL-5 dependent protective immunity to Onchocerca volvulus infective larvae in BALB/cBYJ mice. J. Immunol. 153:205-211[Abstract]. |
| 27. | Lantero, S., O. Sacco, C. Scala, and G. A. Rossi. 1997. Stimulation of blood mononuclear cells of atopic children with the relevant allergen induces the release of eosinophil chemotaxins such as IL-3, IL-5, and GM-CSF. J. Asthma 34:141-152[Medline]. |
| 28. | Lawrence, R. A., J. E. Allen, W. F. Gregory, M. Kopf, and R. M. Maizels. 1995. Infection of IL-4-deficient mice with the parasitic nematode Brugia malayi demonstrates that host resistance is not dependent on a T helper 2-dominated immune response. J. Immunol. 154:5995-6001[Abstract]. |
| 29. | Leke, R. G., W. M. Boto, G. Lando, and J. L. Ngu. 1989. Immunity to Onchocerca volvulus. Serum mediated leucocyte adherence to infective larvae in vitro. Trop. Med. Parasitol. 40:39-41[Medline]. |
| 30. | Lok, J. B., and D. Abraham. 1992. Animal models for the study of immunity in human filariasis. Parasitol. Today 8:168-171[CrossRef][Medline]. |
| 31. | Lucius, R., G. Textor, A. Kern, and C. Kirsten. 1991. Acanthocheilonema viteae: vaccination of Jirds with irradiation-attenuated stage-3 larvae and with exported larval antigens. Exp. Parasitol. 73:184-196[CrossRef][Medline]. |
| 32. | Luder, C. G., H. Schulz-Key, M. Banla, S. Pritze, and P. T. Soboslay. 1996. Immuno-regulation in onchocerciasis: predominance of Th1-type responsiveness to low molecular weight antigens of Onchocerca volvulus in exposed individuals without microfilaridermia and clinical disease. Clin. Exp. Immunol. 105:245-253[CrossRef][Medline]. |
| 33. | Lustigman, S., T. Huima, B. Brotman, K. Miller, and A. M. Prince. 1990. Onchocerca volvulus: biochemical and morphological characteristics of the surface of third- and fourth-stage larvae. Exp. Parasitol. 71:489-495[CrossRef][Medline]. |
| 34. | Maizels, R. M., D. A. Bundy, M. E. Selkirk, D. F. Smith, and R. M. Anderson. 1993. Immunological modulation and evasion by helminth parasites in human populations. Nature 365:797-805[CrossRef][Medline]. |
| 35. | Meredith, S. E., G. Lando, A. A. Gbakima, P. A. Zimmerman, and T. R. Unnasch. 1991. Onchocerca volvulus: application of the polymerase chain reaction to identification and strain differentiation of the parasite. Exp. Parasitol. 73:335-344[CrossRef][Medline]. |
| 36. | Ngu, J. L., C. Tume, G. Lando, P. Ndumbe, R. G. Leke, V. Titanji, and T. Asonganyi. 1989. Comparative studies of clinical groups of patients in an onchocerciasis endemic area for evidence of immune-mediated protection. Trop. Med. Parasitol. 40:460-463[Medline]. |
| 37. | Ottesen, E. A. 1995. Immune responsiveness and pathogenesis of human onchocerciasis. J. Infect. Dis. 171:659-671[Medline]. |
| 38. | Plier, D. A., K. Awadzi, and D. O. Freedman. 1996. Immunoregulation in onchocerciasis: persons with ocular inflammatory disease produce a Th2-like response to Onchocerca volvulus antigen. J. Infect. Dis. 174:380-386[Medline]. |
| 39. | Prince, A. M., B. Brotman, E. H. Johnson, A. Smith, D. Pasqual, and S. Lustigman. 1992. Onchocerca volvulus: immunization of chimpanzees with X-irradiated third stage larvae. Exp. Parasitol. 74:239-250[CrossRef][Medline]. |
| 40. | Rainbird, M. A., D. MacMillan, and E. N. Meeusen. 1998. Eosinophil-mediated killing of Haemonchus contortus larvae: effect of eosinophil activation and role of antibody, complement and interleukin-5. Parasite Immunol. 20:93-103[Medline]. |
| 41. | Selkirk, M. E., R. M. Maizels, and M. Yazdanbaksh. 1992. Immunity and the prospects for vaccination against filariasis. Immunobiology 184:263-281[Medline]. |
| 42. | Soboslay, P. T., C. M. Dreweck, H. R. Taylor, B. Brotman, P. Wenk, and B. M. Greene. 1991. Experimental onchocerciasis in chimpanzees. Cell-mediated immune responses, and production and effects of IL-1 and IL-2 with Onchocerca volvulus infection. J. Immunol. 147:346-353[Abstract]. |
| 43. | Soboslay, P. T., S. M. Geiger, N. Weiss, M. Banla, C. G. Luder, C. M. Dreweck, E. Batchassi, B. A. Boatin, A. Stadler, and H. Schulz-Key. 1997. The diverse expression of immunity in humans at distinct states of Onchocerca volvulus infection. Immunology 90:592-599[CrossRef][Medline]. |
| 44. | Steel, C., and T. B. Nutman. 1993. Regulation of IL-5 in onchocerciasis. A critical role for IL-2. J. Immunol. 150:5511-5518[Abstract]. |
| 45. | Taylor, M. J., R. P. Van Es, K. Shay, S. G. Folkard, S. Townson, and A. E. Bianco. 1994. Protective immunity against Onchocerca volvulus and Onchocerca lienalis infective larvae in mice. Trop. Med. Parasitol. 45:17-23[Medline]. |
| 46. | Taylor, M. J., R. E. Jenkins, and A. E. Bianco. 1998. Protective immunity induced by vaccination with Onchocerca volvulus tropomyosin in rodents. Parasite Immunol. 18:219-225. |
| 47. | Tsang, V. C., A. E. Boyer, J. B. Pilcher, M. L. Eberhard, C. B. Reimer, G. Zea-Flores, W. Zhou, and F. O. Richards. 1991. Guatemalan human onchocerciasis. Systemic analysis of patient populations, nodular antigens and specific isotypic reactions. J. Immunol. 146:3993-4000[Abstract]. |
| 48. | Ward, D. J., T. B. Nutman, G. Zea-Flores, C. Portocarrero, A. Lujan, and E. A. Ottesen. 1988. Onchocerciasis and immunity in humans: enhanced T cell responsiveness to parasite antigen in putatively immune individuals. J. Infect. Dis. 157:536-543[Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»